Article: BD Presents New Blood Glucose Monitoring Products and Announces Strategic Relationships with Medtronic MiniMed and Eli Lilly and Company.

Health/Medical Writers

FRANKLIN LAKES, N.J.--(BUSINESS WIRE)--Jan. 8, 2003

BD (Becton, Dickinson and Company) (NYSE:BDX) today introduced two new FDA-cleared blood glucose monitoring products, the BD Logic(TM) Blood Glucose Monitor and the BD Latitude(TM) Diabetes Management System, both of which will be available in the United States.

As part of the new product launches, BD has entered into two separate and unrelated strategic relationships with industry leaders Medtronic MiniMed, the diabetes management business of Medtronic, Inc. (NYSE: MDT), and Eli Lilly and Company (Lilly) (NYSE: LLY) to increase its diabetes care market presence.

...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!